Diastolic Dysfunction and Interstitial Lung Edema in Septic Patients

Sponsor
Universitätsklinikum Hamburg-Eppendorf (Other)
Overall Status
Completed
CT.gov ID
NCT03768752
Collaborator
(none)
83
1
6.7
12.4

Study Details

Study Description

Brief Summary

Sepsis is one of the most challenging conditions with an exceptionally high mortality rate. Diastolic Dysfunction is common in septic patients and has been found to be associated with mortality. However, the reasons for this remain unclear. Therefore, the goal of this study is to investigate diastolic dysfunction in septic patients on the intensive care unit. Special attention is paid to the presence of lung edema and general edema as a potential link between diastolic dysfunction and elevated mortality in septic patients. During the septic phase daily ultrasound examinations of heart and lung will be performed as to monitor diastolic function and lung edema.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    83 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Left Ventricular Diastolic Dysfunction as a Risk Factor for Interstitial Lung Edema in Septic Patients on the Intensive Care Unit
    Actual Study Start Date :
    Oct 11, 2018
    Actual Primary Completion Date :
    May 3, 2019
    Actual Study Completion Date :
    May 3, 2019

    Arms and Interventions

    Arm Intervention/Treatment
    Diastolic Dysfunction

    Patients with pre-existing or new diastolic dysfunction.

    Normal Diastolic Function

    Patients with normal diastolic function.

    Outcome Measures

    Primary Outcome Measures

    1. Diastolic Dysfunction [While in septic condition, up to 10 days maximum.]

      Diastolic Dysfunction specified by echocardiographic doppler derived mitral inflow pattern and tissue doppler derived diastolic mitral annular velocities (E/E').

    2. Pulmonary Edema [While in septic condition, up to 10 days maximum.]

      Pulmonary edema specified by B line ultrasound score (Lung ultrasound protocol for the assessment of pulmonary fluid status according to Enghardt et al. 2015).

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients on the intensive care unit diagnosed with SIRS (systemic inflammatory response syndrome) or Sepsis.
    Exclusion Criteria:
    • Patients with hemodynamically relevant cardiac defects.

    • Patients with mitral valve replacement.

    • Patients with pericardial effusion.

    • Patients with atrial fibrillation.

    • Patients with pacemaker therapy.

    • Patients with BMI > 35 kg/m2.

    • Patients with poor examination conditions for ultrasound.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Universitätskrankenhaus Hamburg-Eppendorf Hamburg Germany 20246

    Sponsors and Collaborators

    • Universitätsklinikum Hamburg-Eppendorf

    Investigators

    • Principal Investigator: Ursula Kahl, MD, Klinik und Poliklinik für Anästhesie Universitätsklinikum Hamburg-Eppendorf

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Ursula Kahl, Dr. med., Universitätsklinikum Hamburg-Eppendorf
    ClinicalTrials.gov Identifier:
    NCT03768752
    Other Study ID Numbers:
    • DD-Sepsis
    First Posted:
    Dec 7, 2018
    Last Update Posted:
    May 14, 2021
    Last Verified:
    May 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Ursula Kahl, Dr. med., Universitätsklinikum Hamburg-Eppendorf
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 14, 2021